MINOCYCLINE-50 50 MG
MINOCYCLINE (MINOCYCLINE HYDROCHLORIDE) : 50 MG · DIN 02153394 · PRO DOC LIMITEE
Health Canada status: CANCELLED POST MARKET
What is MINOCYCLINE-50?
MINOCYCLINE-50 50 MG contains MINOCYCLINE (MINOCYCLINE HYDROCHLORIDE) : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02153394, held by PRO DOC LIMITEE, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Apr-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is MINOCYCLINE-50 used for?
MINOCYCLINE (minocycline hydrochloride) may be indicated for the treatment of the following infections due to susceptible strains of the designated organisms: Gallbladder infections caused by Escherichia coli; Urinary tract infections: cystitis, gonorrhea, pyelonephritis caused by Escherichia coli, Proteus species, Klebsiella species, Enterobacter aerogenes, Neisseria cionorrhoeae. When penicillin is contraindicated, minocycline may be employed as an alternative drug in the treatment of anal and pharyngeal gonorrhea and syphilis. Skin and soft tissue infections: abscess cellulitis, furunculosis, impetigo and pyoderma caused by: Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus pyogenes, Proteus species, Escherichia coli. Respiratory tract infections: bronchitis, pharyngitis, pneumonia, bronchopneumonia, sinusitis and tonsillitis caused by: Haemophilus influenzae, Klebsiella species, Enterobacter species.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is MINOCYCLINE-50 called?
The same molecule, MINOCYCLINE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Sandoz Minocycline | Latin | South Africa |
| Cyclimycin | Latin | South Africa |
| Minostad | Latin | Iceland |
| MINOTREX | Latin | Morocco |
| MYNOCINE | Latin | Morocco |
| Skid | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02153394 |
|---|---|
| Brand name | MINOCYCLINE-50 |
| Generic / active ingredient | MINOCYCLINE (MINOCYCLINE HYDROCHLORIDE) : 50 MG |
| Manufacturer | PRO DOC LIMITEE |
| Strength | 50 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J01AA08 MINOCYCLINE |
| AHFS class | 08:12.24 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Apr-2019 |
| Original market date | 1995-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02153394 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2153394 |
| Brand name | MINOCYCLINE-50 |
| Active ingredient / INN | MINOCYCLINE (MINOCYCLINE HYDROCHLORIDE) : 50 MG |
| ATC code | J01AA08 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J01 |
| AHFS class | 08:12.24 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | PRO DOC LIMITEE |
How is it stored and handled?
Store at controlled room temperature 15-30°C. Protect from light. Protect blister packs from high humidity.
How is it supplied?
MINOCYCLINE-50 Capsules 50 mg: Available in bottles of 100, 500 and 1000 and in unit dose packages of 30, 100 and 500. MINOCYCLINE-100 Capsules 100 mg: Available in bottles of 100, 500 and 1000 and in unit dose packages of 30, 100 and 500.
Which pack is which?
| Strength on the label | 50 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
| Packaging as described in the monograph | MINOCYCLINE-50 Capsules 50 mg: Available in bottles of 100, 500 and 1000 and in unit dose packages of 30, 100 and 500. MINOCYCLINE-100 Capsules 100 mg: Available in bottles of 100, 500 and 1000 and in unit dose packages of 30, 100 and 500. |
| Storage | Store at controlled room temperature 15-30°C. Protect from light. Protect blister packs from high humidity. |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
What can be used instead?
Other Canadian products sharing ATC code J01AA08 MINOCYCLINE. 2 of 36 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MINOCYCLINE | 100 MG | CAPSULE | AA PHARMA INC | MARKETED | DIN 02084104 |
| MINOCYCLINE | 50 MG | CAPSULE | AA PHARMA INC | MARKETED | DIN 02084090 |
| AVA-MINOCYCLINE | 50 MG | CAPSULE | AVANSTRA INC | CANCELLED PRE MARKET | DIN 02363585 |
| DOM-MINOCYCLINE CAPSULES | 100 MG | CAPSULE | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02239668 |
| DOM-MINOCYCLINE CAPSULES | 50 MG | CAPSULE | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02239667 |
| ENCA 100MG | 100 MG | CAPSULE | PREMPHARM INC | CANCELLED POST MARKET | DIN 02248209 |
| ENCA 50MG | 50 MG | CAPSULE | PREMPHARM INC | CANCELLED POST MARKET | DIN 02248208 |
| MINOCIN | 100 MG | CAPSULE | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | DIN 02173506 |
| MINOCIN | 50 MG | CAPSULE | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | DIN 02173514 |
| MINOCIN CAP 100MG | 100 MG | CAPSULE | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | DIN 00014591 |
Who else supplies MINOCYCLINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. MINOCYCLINE appears in 39 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does MINOCYCLINE cost around the world?
MINOCYCLINE is listed on 7 national price registers Nexara tracks, across 51 pack listings published on 7 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 6 | 29 | 03 Sep 2026 |
| Saudi Arabia | public | 6 | 6 | 01 Sep 2026 |
| South Africa | single exit price | 3 | 6 | 01 Sep 2026 |
| Australia | ex-manufacturer | 2 | 4 | 08 Sep 2026 |
| Greece | producer price (ex-factory) | 2 | 2 | 03 Sep 2026 |
| Iceland | max wholesale | 2 | 2 | 02 Sep 2026 |
| Morocco | PPV (public price) | 2 | 2 | 05 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.